Merck's COVID drug Molnupiravir clears customs : comparemela

The first batch of Molnupiravir, a COVID-19 drug developed by US pharmaceutical company Merck, finished customs clearance at Shanghai Waigaoqiao Free Trade Zone on Friday and entered the domestic market.

Related Keywords

China , Waigaoqiao , Shanghai , Dai Qian , Fujian , Chinese , , National Medical Products Administration , Sinopharm Group , Shanghai Waigaoqiao Free Trade Zone , Waigaoqiao Free Trade Zone , Developed , Sb , Pharmaceutical , Friday , Company , Zone , Merck , Trade , Finishes , Free ,